| 1 |
33147611 | A management of neutropenia using granulocyte colony stimulating factor support for chemotherapy consisted of docetaxel, cisplatin and 5-fluorouracil in patients with oesophageal squamous cell carcinoma. | 2021 Feb 8 |
3 |
| 2 |
33590721 | Safety and efficacy of administering reduced doses of pegylated recombinant human granulocyte-colony stimulating factors in patients treated with cisplatin and etoposide for small cell carcinoma: A retrospective study. | 2021 Apr |
1 |
| 3 |
31742349 | Protective effects of human umbilical cord mesenchymal stem cell-derived conditioned medium on ovarian damage. | 2020 Jun 11 |
2 |
| 4 |
29948238 | Primary prophylactic granulocyte colony-stimulating factor according to ASCO guidelines has no preventive effect on febrile neutropenia in patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy. | 2018 Dec |
2 |
| 5 |
28093087 | Incidence of Venous Thromboembolism in cancer patients treated with Cisplatin based chemotherapy - a cohort study. | 2017 Jan 16 |
1 |
| 6 |
26666576 | The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer. | 2015 Dec 15 |
1 |
| 7 |
24625457 | Plerixafor added to G-CSF-supported paclitaxel-ifosfamide-cisplatin salvage chemotherapy enhances mobilization of adequate numbers of hematopoietic stem cells for subsequent autografting in hard-to-mobilize patients with relapsed/refractory germ-cell tumors: a single-center experience. | 2014 Aug |
1 |
| 8 |
24821366 | Efficacy and safety of early G-CSF administration in patients with head and neck cancer treated by docetaxel-cisplatin and 5-fluorouracil (DCF protocol): a retrospective study. | 2014 Oct |
1 |
| 9 |
23749899 | Cytokine changes in response to radio-/chemotherapeutic treatment in head and neck cancer. | 2013 Jun |
1 |
| 10 |
22993377 | Modified docetaxel-cisplatin in combination with capecitabine as first-line treatment in metastatic gastric cancer. a phase II study. | 2012 Sep |
1 |
| 11 |
20708854 | Preclinical and pilot clinical studies of docetaxel chemoradiation for Stage III non-small-cell lung cancer. | 2011 Aug 1 |
1 |
| 12 |
20300587 | Successful treatment of Cisplatin overdose with plasma exchange. | 2010 |
2 |
| 13 |
20437856 | Long-term results of a pilot study on an intensive induction regimen for unresectable stage III non-small-cell lung cancer. | 2010 Jan-Feb |
1 |
| 14 |
19218307 | Preoperative weekly cisplatin-epirubicin-paclitaxel with G-CSF support in triple-negative large operable breast cancer. | 2009 Jul |
1 |
| 15 |
19619443 | [Induction chemotherapy with docetaxel plus cisplatin (TP regimen) followed by concurrent chemoradiotherapy with TP regimen versus cisplatin in treating locally advanced nasopharyngeal carcinoma]. | 2009 Mar |
2 |
| 16 |
18697197 | Chemotherapeutic drugs and human tumor cells cytokine network. | 2008 Nov 1 |
1 |
| 17 |
17094396 | Subsets of patients with advanced gastric cancer responding to second-line chemotherapy with docetaxel-cisplatin. | 2006 Sep-Oct |
1 |
| 18 |
14665607 | Docetaxel and cisplatin with granulocyte colony-stimulating factor (G-CSF) versus MVAC with G-CSF in advanced urothelial carcinoma: a multicenter, randomized, phase III study from the Hellenic Cooperative Oncology Group. | 2004 Jan 15 |
2 |
| 19 |
15358478 | A patient with granulocyte-colony stimulating factor-producing endometrial cancer who responded to high-dose cisplatin, cyclophosphamide and adriamycin. | 2004 Oct 15 |
1 |
| 20 |
11865633 | [Clinical usefulness of ondansetron injection in patients receiving cancer chemotherapy]. | 2002 Feb |
1 |
| 21 |
11953891 | Modulation of colony stimulating factor release and apoptosis in human colon cancer cells by anticancer drugs. | 2002 Apr 22 |
1 |
| 22 |
11115564 | Prognostic results of cisplatin IP and carboplatin IV with G-CSF in patients with ovarian cancer. | 2001 Jan-Feb |
1 |
| 23 |
11181665 | Phase I trial of escalating doses of paclitaxel combined with fixed doses of cisplatin and doxorubicin in advanced endometrial cancer and other gynecologic malignancies: a Gynecologic Oncology Group study. | 2001 Feb 15 |
1 |
| 24 |
11336465 | A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II study. | 2001 May 4 |
2 |
| 25 |
11735678 | Paclitaxel: a pharmacoeconomic review of its use in non-small cell lung cancer. | 2001 |
1 |
| 26 |
11843253 | Phase I study of pegylated liposomal doxorubicin, paclitaxel, and cisplatin in patients with advanced solid tumors. | 2001 Dec |
1 |
| 27 |
10873410 | Paclitaxel and cisplatin in advanced or recurrent carcinoma of the endometrium: long-term results of a phase II multicenter study. | 2000 Jul |
1 |
| 28 |
11006039 | Cisplatin-paclitaxel-cyclophosphamide with G-CSF in primary advanced epithelial ovarian cancer. | 2000 Oct |
1 |
| 29 |
11016746 | Cisplatin-epirubicin-paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase II study. | 2000 Jul |
1 |
| 30 |
9923557 | Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy: a multicenter phase II trial. | 1999 |
2 |
| 31 |
10071262 | Phase I and pharmacologic study of the combination of paclitaxel, cisplatin, and topotecan administered intravenously every 21 days as first-line therapy in patients with advanced ovarian cancer. | 1999 Mar |
1 |
| 32 |
10210543 | Paclitaxel, 5-fluorouracil, hydroxyurea, and concomitant radiation therapy for poor-prognosis head and neck cancer. | 1999 Apr |
1 |
| 33 |
10321506 | A phase II study of irinotecan and infusional cisplatin with recombinant human granulocyte colony-stimulating factor support for advanced non-small-cell lung cancer. | 1999 |
1 |
| 34 |
10355583 | Cisplatin-topotecan-paclitaxel weekly administration with G-CSF support for ovarian and small-cell lung cancer patients: a dose-finding study. | 1999 Mar |
1 |
| 35 |
10561191 | Erythropoietin addition to granulocyte colony-stimulating factor abrogates life-threatening neutropenia and increases peripheral-blood progenitor-cell mobilization after epirubicin, paclitaxel, and cisplatin combination chemotherapy: results of a randomized comparison. | 1999 Apr |
1 |
| 36 |
9602269 | First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: a multicenter phase II study. | 1998 Mar |
1 |
| 37 |
9694607 | Weekly paclitaxel-cisplatin administration with G-CSF support in advanced breast cancer. A phase II study. | 1998 May |
2 |
| 38 |
9887248 | A phase I study of paclitaxel, doxorubicin, and cisplatin in patients with previously untreated epithelial ovarian cancer. | 1998 Dec |
1 |
| 39 |
9043028 | Paclitaxel, ifosfamide and cisplatin with granulocyte colony-stimulating factor or recombinant human interleukin 3 and granulocyte colony-stimulating factor in ovarian cancer: a feasibility study. | 1997 |
1 |
| 40 |
9053499 | Paclitaxel by 96-hour continuous infusion in combination with cisplatin: a phase I trial in patients with advanced lung cancer. | 1997 Feb |
1 |
| 41 |
9167751 | Standard-dose recombinant human granulocyte colony-stimulating factor (rhG-CSF) allows safe and repeated administration of high-dose cyclophosphamide, etoposide, and cisplatin (CEP). | 1997 Jun |
1 |
| 42 |
9427795 | A new schedule for etoposide, epidoxorubicin and cisplatin with granulocyte colony stimulating factor for advanced gastric cancer: a feasibility study. | 1997 Sep-Oct |
1 |
| 43 |
8629035 | Paclitaxel couplets with cyclophosphamide or cisplatin in metastatic breast cancer. | 1996 Feb |
2 |
| 44 |
8742097 | Different doses of granulocyte colony stimulating factor to support a weekly chemotherapeutic regimen in advanced gastric cancer: a randomized study. | 1996 Jan |
2 |
| 45 |
8774656 | Sequential granulocyte colony-stimulating factor increases cisplatin cytotoxicity in human epithelial ovarian cancer cell lines. | 1996 Mar |
4 |
| 46 |
8841050 | [Combination of irinotecan hydrochloride (CPT-11) and cisplatin as a new regimen for patients with advanced ovarian cancer]. | 1996 Sep |
2 |
| 47 |
8954183 | Impact of recombinant human granulocyte colony stimulating factor on dose intensity and toxicity of three cycles of methotrexate, vinblastine, doxorubicin and cisplatin in patients with previously untreated urothelial bladder carcinoma. | 1996 Sep |
1 |
| 48 |
7474409 | Intensive chemotherapy with cisplatin, doxorubicin, cyclophosphamide, etoposide and granulocyte colony-stimulating factor for advanced thymoma or thymic cancer: preliminary results. | 1995 Oct |
2 |
| 49 |
7530173 | A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest. | 1995 |
2 |
| 50 |
8583722 | [Gingival metastasis of large-cell lung cancer that produced G-CSF]. | 1995 Nov |
1 |